1) 日本胃癌学会編 : 胃癌取扱い規約 第15版, 金原出版, 東京, 2017
1) Petrowsky, H et al : Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma. J Hepatol 45 : 43-50, 2006
2) Kitajima, K et al : Clinical impact of whole body FDG-PET for recurrent biliary cancer : a multicenter study. Ann Nucl Med 23 : 709-715, 2009
2) Yamada, A et al : Evaluation of 2-deoxy-2- [18F] fluoro-D-glucose positron emission tomography in gastric carcinoma : relation to histological subtypes, depth of tumor invasion, and glucose transporter-1 expression. Ann Nucl Med 20 : 597-604, 2006
3) Nakamoto, Y et al : Clinical value of whole-body FDG-PET for recurrent gastric cancer : a multicenter study. Jpn J Clin Oncol 39 : 297-302, 2009
3) Wang, XY et al : The value of 18F-FDG positron emission tomography/computed tomography on the pre-operative staging and the management of patients with pancreatic carcinoma. Hepatogastroenterology 61 : 2102-2109, 2014
4) Asagi, A et al : Utility of contrast-enhanced FDG PET/CT in the clinical management of pancreatic cancer : impact on diagnosis, staging, evaluation of treatment response, and detection of recurrence. Pancreas 42 : 11-19, 2013
4) Ott, K et al : Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging : results of a prospective trial. J Clin Oncol 21 : 4604-4610, 2003
5) Fuccio, C et al : Restaging clear cell renal carcinoma with 18F-FDG PET/CT. Clin Nucl Med 39 : e320-e324, 2014
5) 日本肝癌研究会編 : 原発性肝癌取扱い規約 第6版補訂版, 金原出版, 東京, 2019
6) Torizuka, T et al : In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG PET. J Nucl Med 36 : 1811-1817, 1995
6) van Hoeij, FB et al : Incidental colonic focal FDG uptake on PET/CT : can the maximum standardized uptake value (SUVmax) guide us in the timing of colonoscopy? Eur J Nucl Med Mol Imaging 42 : 66-71, 2015
7) Hatano, E et al : Preoperative positron emission tomography with fluorine-18-fluorodeoxyglucose is predictive of prognosis in patients with hepatocellular carcinoma after resection. World J Surg 30 : 1736-1741, 2006
8) Kong, YH et al : Positron emission tomography with fluorine-18-fluorodeoxyglucose is useful for predicting the prognosis of patients with hepatocellular carcinoma. Korean J Hepatol 10 : 279-287, 2004
9) Anderson, CD et al : Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg 8 : 90-97, 2004
10) 日本膵臓学会編 : 膵癌取扱い規約 第7版補訂版, 金原出版, 東京, 2020
11) 日本泌尿器科学会ほか編 : 膀胱癌取扱い規約 第3版, 金原出版, 東京, 2001
12) Maffione, AM et al : Diagnostic accuracy and impact on management of (18) F-FDG PET and PET/CT in colorectal liver metastasis : a meta-analysis and systematic review. Eur J Nucl Med Mol Imaging 42 : 152-163, 2015
13) Akhurst, T et al : Recent chemotherapy reduces the sensitivity o [f 18F] fluorodeoxyglucose positron emission tomography in the detection of colorectal metastases. J Clin Oncol 23 : 8713-8716, 2005
14) Ozkan, E et al : The role of 18F-FDG PET/CT in detecting colorectal cancer recurrence in patients with elevated CEA levels. Nucl Med Commun 33 : 395-402, 2012
15) 大腸癌研究会編 : 大腸癌取扱い規約 第9版, 金原出版, 東京, 2018